Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04995835 · ClinicalTrials.gov registry record · Phase 1
Cefiderocol PK in Patients on ECMO
A Phase 1 study, sponsored by Joseph L. Kuti, PharmD.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT04995835 is a Phase 1 study that has completed, run by Joseph L. Kuti, PharmD. The registered enrollment target is 5 participants.
The verdict
NCT04995835, a Phase 1 study, has completed, sponsored by Joseph L. Kuti, PharmD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
Extracorporeal membrane oxygenation (ECMO) is a form of cardiopulmonary life-support for critically ill patients where blood is extracted from the vascular system and circulated by a mechanical pump while it is oxygenated and reinfused into the patient's circulation. It is well known that critically ill patients may experience alterations in antibiotic pharmacokinetics, and as a result, dosing modifications are generally required. There is a need to understand how ECMO circuits affect the pharmacokinetics and disposition of drugs. This study is designed to assess the pharmacokinetics of the new broad-spectrum antibiotic, Cefiderocol, in critically ill patient receiving ECMO.
Interventions
- DRUG Cefiderocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-07-16 |
| Est. Completion | 2024-09-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04995835
The ClinicalTrials.gov registry entry for NCT04995835 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joseph L. Kuti, PharmD, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cefiderocol is the first listed.
NCT04995835 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04995835 about?
NCT04995835 is a clinical study titled "Cefiderocol PK in Patients on ECMO". Extracorporeal membrane oxygenation (ECMO) is a form of cardiopulmonary life-support for critically ill patients where blood is extracted from the vascular system and circulated by a mechanical pump while it is oxygenated and reinfused into the patient's circulation. It is well known that critically...
What is the current status of trial NCT04995835?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2021-07-16. Estimated completion is 2024-09-01.
What interventions are being tested in trial NCT04995835?
The interventions under investigation include: Cefiderocol (DRUG).
Who is sponsoring clinical trial NCT04995835?
This trial is sponsored by Joseph L. Kuti, PharmD, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.